{"version":"1.0","provider_name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","provider_url":"https:\/\/microncro.com","author_name":"info@digitalcube.jp","author_url":"https:\/\/microncro.com\/archives\/post\/author\/infodigitalcube-jp\/","title":"Video:Comparison of the CDE Guidance and the FDA Guidance | Micron, Inc. | Molecular Imaging CRO Network","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"4AALQyxKyN\"><a href=\"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/\">Video:Comparison of the CDE Guidance and the FDA Guidance<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/embed\/#?secret=4AALQyxKyN\" width=\"600\" height=\"338\" title=\"&#8220;Video:Comparison of the CDE Guidance and the FDA Guidance&#8221; &#8212; \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\" data-secret=\"4AALQyxKyN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/microncro.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"In recent years, there has been a noticeable increase in clinical trials of anticancer drugs in China.Specifically, imaging endpoints derived from medical imaging assessments as surrogate endpoints are being chosen for more clinical trials.In January 2021, the Centre for Drug Evaluation of China, the CDE, published guidance for the imaging endpoint process, especially focusing on [&hellip;]","thumbnail_url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","thumbnail_width":1200,"thumbnail_height":630}